LN-145
25-394
Phase 2 mab active
Quick answer
LN-145 for Cutaneous Squamous Cell Carcinoma is a Phase 2 program (mab) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IOVANCE BIOTHERAPEUTICS, INC.
- Indication
- Cutaneous Squamous Cell Carcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active